Perrigo
Headquartered in Ireland, Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products and receives royalties from Multiple Sclerosis drug Tysabri.
In 2013 it acquired Irish pharma company Elan.
Financial Data
-
31st Dec 19 Source: CRO
- €4.4 billion turnover
-
€154.4 million
profit - 10,400 employees
-
31st Dec 18 Source: CRO
- €4.2 billion turnover
-
€255.3 million
profit - 10,400 employees
- 5 more years available »
Ranking
By Turnover
(€4.4 billion)- 29th in Top Companies
- 5th in Health
- 5th in Pharma
By Employees
(10,400)- 22nd in Top Companies
- 4th in Health
- 4th in Pharma
-
- 10,400
- €4.4 billion
Employees
- Murray S. Kessler CEO/Managing Director
Latest News
- 2:29pm Covid-19 vaccine sprint as Pfizer-BioNTech, Moderna seek emergency EU approval
- 1:31pm Central Bank offers to assist with coronavirus contact tracing
- 1:01pm Judge rejects examinership application for Ina’s Kitchen Desserts
- 10:27am OECD sees global economy turning the corner on coronavirus crisis
- 10:17am Debenhams set to close all stores after starting liquidation process